Recent advances in targeted strategies for triple-negative breast cancer

Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer, negatively expresses estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (HER2). Although chemotherapy is the main form of treatment for patients with TNBC, the effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shuangli, Wu, Yuze, Song, Bin, Yi, Ming, Yan, Yuheng, Mei, Qi, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464091/
https://www.ncbi.nlm.nih.gov/pubmed/37641116
http://dx.doi.org/10.1186/s13045-023-01497-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464091/
https://www.ncbi.nlm.nih.gov/pubmed/37641116
http://dx.doi.org/10.1186/s13045-023-01497-3

Ejemplares similares